Characterization of folate-chitosan-DNA nanoparticles for gene therapy

被引:338
作者
Mansouri, S
Cuie, Y
Winnik, F
Shi, Q
Lavigne, P
Benderdour, M
Beaumont, E
Fernandes, JC
机构
[1] Hop Sacre Coeur, Ctr Rech, Lab Rech Orthopedia, Montreal, PQ H4J 1C5, Canada
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[3] Ecole Polytech Montreal, Inst Genie Biomed, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
chitosan; nanoparticles; folic acid; gene therapy; DNA;
D O I
10.1016/j.biomaterials.2005.09.020
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Gene therapy using polymers such as chitosan shows good biocompatibility, but low transfection efficiency. The mechanism of folic acid (FA) uptake by cells to promote targeting and internalization could improve transfection rates. The objective of this study was to synthesize and characterize FA-chitosan-DNA nanoparticles and evaluate their cytotoxicity in vitro. Chitosan-DNA and FA-Chitosan-DNA nanoparticles were prepared using reductive amidation and a complex coacervation process. The effect of charge ratio on the properties of these nanoparticles was monitored by laser scattering. DNA inclusion and integrity was evaluated by gel electrophoresis. Cell viability was illustrated with the MTT assay. Charge ratio (NIP) controlled the nanoparticles size and their zeta potential. Nanoparticles presented a mean size of 118 nm and 80% cellular viability compared to 30% cell viability using LipofectAMINE2000 controls. Gel electrophoresis showed intact DNA within the carriers. FA-nanoparticles have lower cytoxicity, good DNA condensation, positive zeta potential and particle size around 118 nm, which makes them a promising candidate as a non-viral gene vector. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2060 / 2065
页数:6
相关论文
共 28 条
[1]   Folate receptors [J].
Antony, AC .
ANNUAL REVIEW OF NUTRITION, 1996, 16 :501-521
[2]   Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J].
Corsi, K ;
Chellat, F ;
Yahia, L ;
Fernandes, JC .
BIOMATERIALS, 2003, 24 (07) :1255-1264
[3]   Chitosan-based nanoparticles for topical genetic immunization [J].
Cui, ZR ;
Mumper, RJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 75 (03) :409-419
[4]   Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].
Dash, PR ;
Read, ML ;
Barrett, LB ;
Wolfert, M ;
Seymour, LW .
GENE THERAPY, 1999, 6 (04) :643-650
[5]   Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates [J].
Dubé, D ;
Francis, M ;
Leroux, JC ;
Winnik, FM .
BIOCONJUGATE CHEMISTRY, 2002, 13 (03) :685-692
[6]   Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability [J].
Erbacher, P ;
Zou, SM ;
Bettinger, T ;
Steffan, AM ;
Remy, JS .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1332-1339
[7]   NLS bioconjugates for targeting therapeutic genes to the nucleus [J].
Escriou, V ;
Carrière, M ;
Scherman, D ;
Wils, P .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (02) :295-306
[8]   Gene therapies for osteoarthritis. [J].
Evans C.H. .
Current Rheumatology Reports, 2004, 6 (1) :31-40
[9]   Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH [J].
Fang, N ;
Chan, V ;
Mao, HQ ;
Leong, KW .
BIOMACROMOLECULES, 2001, 2 (04) :1161-1168
[10]   In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints -: Prevention of osteoarthritis progression [J].
Fernandes, J ;
Tardif, G ;
Martel-Pelletier, J ;
Lascau-Coman, V ;
Dupuis, M ;
Moldovan, F ;
Sheppard, M ;
Krishnan, BR ;
Pelletier, JP .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :1159-1169